<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>46(1)</volume><submitter>Luo Y</submitter><funding>Fundació Institució dels Centres de Recerca de Catalunya</funding><pubmed_abstract>Type II interferon (IFN) immunity is crucial for controlling intramacrophagic infections, driven by the interaction between innate immunity (macrophage-derived IL-12) and adaptive immunity (Th-derived IFN-γ). This study examines the maturation of type II IFN immunity in 55 healthy children (ages 1-18) to enable proper identification of deficiencies as part of the diagnostic evaluation of Mendelian Susceptibility to Mycobacterial Diseases (MSMD). The IL-12/IFN-γ axis was assessed through: (1) cytokine production after mycobacterial stimulation (Luminex and ELISA for IFN-γ, IL-12p70, TNF, CXCL10, IL-1RA, IL-10, IL-1β and IL-6), (2) IFN-γR1/R2 expression on monocytes, and (3) STAT1 phosphorylation/dephosphorylation. T cell maturation (primary IFN-γ source) was evaluated via immunophenotyping (naïve/memory/activated, Th1; Th2; Th17; Th1/17; Tfh) and proliferation assays. Main findings: (1) stable expression/production of key components of the IL-12/IFN-γ axis (IFN-γ, IL-12, TNF, IFN-γR1/2, and STAT1 activity) across ages confirming the stability of innate immune function throughout childhood; (2) increasing responses to IFN-γ with age reflected by increased CXCL10 production, and increase in the IFN-γ counter-acting anti-inflammatory cytokines (IL-10, IL-1RA); and (3) progressive T cell maturation, including Th1, Th17 and Th1/17 subsets, with significant milestones between 6 and 8.6 years, while T cell proliferative capacity remained stable. These observations highlight the stability of IL-12/IFN-γ axis innate components with age, accompanied by enhanced downstream IFN-γ signaling, aligning with the maturation of Th cell compartment. These underscore the limited benefit of age-specific controls in the evaluation of IL-12/IFN-γ axis in MSMD diagnosis, while emphasizing the importance of T cell maturation in the overall type II IFN immunity.</pubmed_abstract><journal>Journal of clinical immunology</journal><pagination>13</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12831799</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Age-Related Patterns of Type II Interferon Immunity: Implications for Intramacrophagic Infections and MSMD Diagnosis During Childhood.</pubmed_title><pmcid>PMC12831799</pmcid><pubmed_authors>Marquez J</pubmed_authors><pubmed_authors>Juan M</pubmed_authors><pubmed_authors>Acevedo D</pubmed_authors><pubmed_authors>Alsina L</pubmed_authors><pubmed_authors>Codina A</pubmed_authors><pubmed_authors>Peiro S</pubmed_authors><pubmed_authors>Marti-Castellote C</pubmed_authors><pubmed_authors>Bolano V</pubmed_authors><pubmed_authors>Jou C</pubmed_authors><pubmed_authors>Freixedas A</pubmed_authors><pubmed_authors>Esteve-Sole A</pubmed_authors><pubmed_authors>Deya-Martinez A</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Garcia-Garcia A</pubmed_authors><pubmed_authors>Arguello G</pubmed_authors><pubmed_authors>Vlagea A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Age-Related Patterns of Type II Interferon Immunity: Implications for Intramacrophagic Infections and MSMD Diagnosis During Childhood.</name><description>Type II interferon (IFN) immunity is crucial for controlling intramacrophagic infections, driven by the interaction between innate immunity (macrophage-derived IL-12) and adaptive immunity (Th-derived IFN-γ). This study examines the maturation of type II IFN immunity in 55 healthy children (ages 1-18) to enable proper identification of deficiencies as part of the diagnostic evaluation of Mendelian Susceptibility to Mycobacterial Diseases (MSMD). The IL-12/IFN-γ axis was assessed through: (1) cytokine production after mycobacterial stimulation (Luminex and ELISA for IFN-γ, IL-12p70, TNF, CXCL10, IL-1RA, IL-10, IL-1β and IL-6), (2) IFN-γR1/R2 expression on monocytes, and (3) STAT1 phosphorylation/dephosphorylation. T cell maturation (primary IFN-γ source) was evaluated via immunophenotyping (naïve/memory/activated, Th1; Th2; Th17; Th1/17; Tfh) and proliferation assays. Main findings: (1) stable expression/production of key components of the IL-12/IFN-γ axis (IFN-γ, IL-12, TNF, IFN-γR1/2, and STAT1 activity) across ages confirming the stability of innate immune function throughout childhood; (2) increasing responses to IFN-γ with age reflected by increased CXCL10 production, and increase in the IFN-γ counter-acting anti-inflammatory cytokines (IL-10, IL-1RA); and (3) progressive T cell maturation, including Th1, Th17 and Th1/17 subsets, with significant milestones between 6 and 8.6 years, while T cell proliferative capacity remained stable. These observations highlight the stability of IL-12/IFN-γ axis innate components with age, accompanied by enhanced downstream IFN-γ signaling, aligning with the maturation of Th cell compartment. These underscore the limited benefit of age-specific controls in the evaluation of IL-12/IFN-γ axis in MSMD diagnosis, while emphasizing the importance of T cell maturation in the overall type II IFN immunity.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-06T22:26:17.085Z</modification><creation>2026-06-06T03:07:55.973Z</creation></dates><accession>S-EPMC12831799</accession><cross_references><pubmed>41452432</pubmed><doi>10.1007/s10875-025-01955-2</doi></cross_references></HashMap>